MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition | Journal of Experimental Medicine | Rockefeller University Press
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition | Journal of Experimental Medicine | Rockefeller University Press
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition | Journal of Experimental Medicine | Rockefeller University Press,Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer,Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress,MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition | Journal of Experimental Medicine | Rockefeller University Press,MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition | Journal of Experimental Medicine | Rockefeller University Press